A lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice against lethal SARS-CoV-2 i...
A lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice against lethal SARS-CoV-2 infection
About this item
Full title
Author / Creator
Elia, Uri , Shahar Rotem , Bar-Haim, Erez , Ramishetti, Srinivas , Gonna Somu Naidu , Gur, David , Aftalion, Moshe , Israeli, Ma'ayan , Bercovich-Kinori, Adi , Alcalay, Ron , Makdasi, Efi , Chitlaru, Theodor , Rosenfeld, Ronit , Israely, Tomer , Melamed, Sharon , Ionita, Inbal Abutbul , Danino, Dganit , Peer, Dan and Cohen, Ofer
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
The current global COVID-19 pandemic led to an unprecedented effort to develop effective vaccines against SARS-CoV-2. mRNA vaccines were developed very rapidly during the last year, and became the leading immunization platform against the virus, with highly promising phase-3 results and remarkable efficacy data. Since most animal models are not sus...
Alternative Titles
Full title
A lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice against lethal SARS-CoV-2 infection
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2506832025
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506832025
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/2021.03.29.436639
How to access this item
https://www.proquest.com/docview/2506832025?pq-origsite=primo&accountid=13902
